secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001021771-23-000094
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BRTX stockholders elect directors, approve share increase, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Class III directors Lance Alstodt and Patrick F. Williams elected with 864,671 and 662,099 votes for, respectively.
- Amendment to 2021 Stock Incentive Plan approved: 571,623 for, 276,247 against, 1,907,427 broker non-votes.
- Marcum LLP ratified as independent auditor for FY 2023: 2,751,541 for, 15,525 against.
- Plan amendment increases authorized shares from 2.5M to 3.85M.
- All proposals passed despite significant broker non-votes on director election and plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/0001021771-23-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/brt8kdtd091323.htm
  HTML page:      https://secwatch.observer/filing/0001021771-23-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer